Apyx Medical Posts Encouraging Data From Renuvion Device In Sagging Skin
February 2, 2024
CNBC
Apyx Medical Corp (NASDAQ: APYX ) announced results from Phase 2 of its Investigational Device Exemption (IDE) study of the Renuvion device to improve the appearance of lax skin in the neck and submental region.
The 65-subject study showed that the primary effectiveness ... Full story available on Benzinga.com
SweepCast
Simplest Unusual Options Activity Platform for traders. SweepCast can be used for swing or day traders who are looking to get insights on where Smart money is flowing, sign up today.